The effectiveness of antidepressants in elderly depressed outpatients: A prospective case series study

Journal of Clinical Psychiatry

Volumn 60, Issue 10, 1999, Pages 690-697

  Mittmann, Nicole ^a,b   Herrmann, Nathan ^a   Shulman, Kenneth I ^a   Silver, Ivan L ^a   Busto, Usoa E ^a   Borden, E Keith ^c   Naranjo, Claudio A ^a   Shear, Neil H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE MALEATE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE;

AGED; ARTICLE; CONSTIPATION; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GERIATRIC DISORDER; HUMAN; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; OUTPATIENT; PRIORITY JOURNAL; URINE INCONTINENCE; XEROSTOMIA;

EID: 0032718339     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v60n1008     Document Type: Article

References (23)

1. Mittmann N, Hermann N, Einarson TR, et al. The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis. J Affect Disord 1997;46:191-217
2. Herrmann N, Bremner KE, Naranjo CA. Pharmacotherapy of late life mood disorders. Clin Neurosci 1997;4:41-47
3. Anstey K, Brodaty H. Antidepressants and the elderly: double-blind trials 1987-1992. Int J Geriatr Psychiatry 1995;10:265-279
4. Strom BL. Pharmacoepidemiology. New York, NY: John Wiley & Sons; 1994
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987
6. World Health Organization. Anatomical Therapeutic Chemical (ATC) Classification Index including defined daily doses (DDDs) for plain substances. Oslo, Norway: World Health Organization Collaborating Centre for Drugs; 1995
7. Linn B, Linn M, Gurel L. Cumulative Illness Rating Scale. J Am Geriatr Soc 1968;16:622-626
8. Montgomery SA, Asberg MC. A new depression rating scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389
9. Mittmann N, Mitter S, Borden EK, et al. Montgomery-Asberg severity gradations [letter]. Am J Psychiatry 1997;154:1320-1321
10. Beers M, Ouslander J. Risk factors in geriatric drug prescribing: a practical guide to avoiding problems. Drugs 1989;37:105-112
11. Anderson G, Carter JA. Patterns of use of specific drugs in the elderly: antidepressants, antibiotics and drugs to be avoided in the elderly. In: Goel V, Williams J, Anderson G, et al., eds. Patterns of Health Care in Ontario: ICES Practice Atlas. 2nd ed. Ottawa, Ontario: Canadian Medical Association; 1996:323-328
12. Burrows GD, Vohra J, Hunt D, et al. Cardiac effects of different tricyclic antidepressant drugs. Br J Psychiatry, 1976;129:335-341
13. Roose SP, Glassman AH, Siris SG, et al. Comparison of imipramine- and nortriptyline-induced orthostatic hypotension: a meaningful difference. J Clin Psychopharmacol 1981;1:316-321
14. IMS Canada. Depression Prescription Trends. Toronto, Ontario, Canada: IMS Canada; 1996
15. Parker KL, Mittmann N, Shear NH, et al. Lithium augmentation in geriatric depressed outpatients: a clinical report. Int J Geriatr Psychiatry 1994;9: 995-1002
16. Flint A, Rifat S. A prospective study of lithium augmentation in antidepressant-resistant geriatric depression. J Clin Psychopharmacol 1994; 14:353-356
17. Kalant H, Roschlau WHE, eds. Principles of Medical Pharmacology. Toronto, Canada: BC Decker Inc; 1997
18. Rosholm JU, Hallas J, Gram LF. Outpatient utilization of antidepressants: a prescription database analysis. J Affect Disord 1993;27:21-28
19. Feighner JP, Boyer WF, Meredith CH, et al. An overview of fluoxetine in geriatric depression. Br J Psychiatry 1988;153(suppl):105-108
20. Feighner JP, Cohn JB. Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. J Clin Psychiatry 1985;46(3, sec 2):20-25
21. Kamath M, Finkel SI, Moran M. A retrospective chart review of antidepressant use, effectiveness and adverse events in adults age 70 and older. Am J Geriatr Psychiatry 1996;4:167-172
22. Preskorn SH. Recent pharmacologic advances in antidepressant therapy for the elderly [review]. Am J Med 1993;94(5A):2S-12S
23. Hunter KD, Wilson WS. The effects of antidepressant drugs on salivary flow and content of sodium and potassium ions in human parotid saliva. Arch Oral Biol 1995;40:983-989